255
Participants
Start Date
November 30, 2010
Primary Completion Date
July 31, 2011
Study Completion Date
September 30, 2011
20 micrograms dose H5 VLP
2 doses given 21 days apart of 20 micrograms of H5 VLP vaccine mixed with Alhydrogel
30 micrograms dose H5 VLP
2 doses given 21 days apart of 30 micrograms of H5 VLP vaccine mixed with Alhydrogel
45 micrograms dose H5 VLP
2 doses given 21 days apart of 45 micrograms of H5 VLP vaccine mixed with Alhydrogel
45 micrograms non-adjuvanted H5 VLP
2 doses given 21 days apart of 45 micrograms of H5 VLP vaccine
Placebo
2 doses given 21 days apart of the placebo
Kendle Early Stage, Toronto
Lead Sponsor
Collaborators (1)
Syneos Health
OTHER
Medicago
INDUSTRY